According to Bionomics's latest financial reports the company's current EPS (TTM) is -3,29 โฌ. In 2022 the company made an earnings per share (EPS) of -3,29 โฌ a decrease over its 2021 EPS that were of -1,39 โฌ.
Year | EPS | Change |
---|---|---|
2022 | -3,29 โฌ | 137.66% |
2021 | -1,39 โฌ | 7.34% |
2020 | -1,29 โฌ | -30.72% |
2019 | -1,86 โฌ | -64.88% |
2018 | -5,30 โฌ | 243.83% |
2017 | -1,54 โฌ | -60.32% |
2016 | -3,89 โฌ | -11.65% |
2015 | -4,40 โฌ | -507.39% |
2014 | 1,08 โฌ | -130.56% |
2013 | -3,53 โฌ | 169.05% |
2012 | -1,31 โฌ | -70.28% |
2011 | -4,42 โฌ | 36.51% |
2010 | -3,24 โฌ | 0.63% |
2009 | -3,22 โฌ | 12.2% |
2008 | -2,87 โฌ | -34.98% |
2007 | -4,41 โฌ | 22.52% |
2006 | -3,60 โฌ | -46.29% |
2005 | -6,70 โฌ | -2.7% |
2004 | -6,89 โฌ | -34.51% |
2003 | -10,52 โฌ | 18.95% |
2002 | -8,84 โฌ | -13.64% |
2001 | -10,24 โฌ | 10% |
2000 | -9,31 โฌ | -1.34% |
1999 | -9,43 โฌ |